Immature dendritic cells (DCs) modulate differentiation markers following in vitro exposure to chemicals generating contact allergies. THP-l is a monocytoid cell line maintaining some differentiating plasticity. In this study, human DCs and THP-l cells were compared as in vitro models to predict contact sensitisation ofchemicals with different sensitising potential. Expression of CD80 and CD86 was assessed by flow cytometry after exposure to sub toxic concentrations of potent (2,4-dinitrochlorobenzene, DNCB and p-phenylendiamine, PPD), strong (thimerosal, TMS), moderate (sodium tetrachloroplatinate, Na 2PtCI4 ) sensitising compounds as well as of non-sensitising, irritating sodium dodecyl sulphate (SDS) as compared to a vehicle of sensitising substances (dimethyl sulphoxide, DMSO). Up-regulation of CD86 following in vitro incubation ofDCs and THP-l cells with DNCB, PPD, TMS and Na zPtCI4 but not with SDS, was observed. The CD80 membrane marker was up-regulated on DCs following in vitro incubation with DNCB and PPD, but not with TMS, Na zPtC14 • and SDS. On THP-l cells, only DNCB up-regulated CD80 expression. In conclusion, both the cell line THP-l and DCs are promising in vitro models for assays aiming at predicting the sensitisation potential of chemicals. THP-l cell line is by far easier to handle and offers relevant advantages from the practical point of view.
Langerhans cells (LCs) of the skin playa crucial role in the induction phase of contact allergy. They bind haptens via major histocompatibility complex (MHC) class II, internalize them (1) , and migrate via afferent lymphatics from skin to draining lymph nodes. During migration, they differentiate to mature dendritic cells (DCs) and change morphologically and phenotypically. In the regional lymph nodes, DCs present the antigen to responsive T cells and generate effector T lymphocytes of contact hypersensitivity (2) . LCs are poorly represented within epidermal cells and are relatively difficult to isolate in sufficient numbers for in vitro studies. In contrast, well-established methods allow generating large numbers of DCs from peripheral blood monocytes (3) which can stimulate naive T cells to effector cells for hypersensitivity reactions (4) . Although several authors proposed the use of cultured DCs as an in vitro model for contact sensitization (5) (6) , they still suffer the limitation of a high inter-individual variability in response to chemicals (6) (7) (8) . As a further possibility, the monocytoid THP-l stable cell line has been proposed (9-10), but its equivalence to primary DCs has not been established.
The aim of the present study is to compare human blood-derived Des with commercially available THP-I cell line as in vitro assay systems for the prediction of contact sensitization potency of chemicals.
MATERIALS AND METHODS

Chemicals and biochemicals
Chemicals with different sensitization potential selected for the study were: 2,4 dinitrochlorobenzene (DNCB), m.wt.=202,55; p-phenylenediamine (PPD), m.wt.=108, I; thimerosal (TMS), m.wt.=406,33; sodium tetrachloroplatinate (NaltCI4), m.wt.= 168; sodium dodecyl sulphate (SDS), m.wt.=288,38, and dimethyl sulfoxide (DMSO), m.wt=78,13. They were obtained from Sigma Aldrich Italia (Milan, Italy) at the highest purity available.
The sensitization potential of these chemicals was previously established, both on the basis of epidemiological evidence in humans as well as of a validated quantitative in vivo assay for the determination of skin sensitization (Local Lymph Node Assay) (ll-12). RPMI-1640, fetal calf serum (FCS), antibiotics, glutamine, streptomycin and penicillin were purchased from PSI International (Milano, Italy). Mouse monoclonal antibodies to human CD3, CD80 (lgG I, k), CD86 (lgG I, k), an isotype-matched monoclonal with irrelevant specificity, recombinant human GM-CSF and IL-4 and Fycoll-Paque were from BD Biosciences Pharmingen (San Diego, CA, USA); Dynabeads M-450 from Dynal Biotech (Oslo, Norway); propidium iodine (PI) and PBS from Sigma Aldrich Italia (Milan, Italy);
THP-I cell line and monocyte-derived DCs
The human myeloid THP-I cell line was obtained from the European Collection of Cell Culture (Salisbury, UK), and maintained in RPMI-1640 medium containing 10% FCS and 2 mM glutamine.
DCs were prepared from heparinised blood collected from a vein of the forearm of six healthy donors (30 ml each donor) recruited at the S. Raffaele Hospital (Milan). All subjects were informed on the scope of the study and gave their written consent that was submitted and approved by the local ethics committee (Protocol DSI URC/ER/mm number 177IDG, San Raffaele Scientific Institute). Immature, monocyte-derived DCs were then isolated from peripheral blood as previously described, with some modifications which were introduced in order to verify rhe.plasticity of the differentiation potential of single preparations of DCs (3) . Standard gradient separation procedures on Fycoll-Paque were used to isolate peripheral blood mononuclear cells (PBMC) which were then re-suspended in RPMI-1640 containing 10% FCS, 2 mM glutamine, 100 Ulml penicillin, 100 ug/ml streptomycin ("complete medium"), and allowed to adhere on 6-well plates (Costar, Cambridge, MA) for I h at 37°C. In antigen-driven proliferation assays, autologus human serum was used in complete medium. Non-adherent cells were discarded. In order to derive immature DCs, PBMC were then cultured for 7 days in complete medium, in the presence of human GM-CSF (50 ng/ml) and IL-4 (1000 U/ml) (3) . Depletion of residual T lymphocytes from immature DCs was carried out by incubating the cell preparations with the anti-CD3 monoclonal antibody (I flg/10 6 cells) followed by goat anti-mouse IgG-eoated Dynabeads M-450. Anti-CD3 bound T cells were removed with a magnet according to manufacturer's instructions. Purified DCs preparations were routinely checked for contaminating lymphocytes by flow cytometry using a fluorescence-activated cell sorter (FACScan plus, Becton Dickinson, Sunnyvale, CA). Residual lymphocytes accounted for less than 1% of total cells. Moreover, DCs preparations were checked for MHC class I and II, CD80, CD83, CD86 and CDla membrane expression.
As a control for the acquisition of the proper differentiation plasticity, DCs were then incubated for 48 h with (mature DCs) or without (immature DCs) LPS (0.2 pg/ml) and the expression of both CD80 and CD86 membrane markers was assessed by flow cytometry, Only cellular preparations of mature (i.e. LPS-treated) DCs displaying a CD80 and CD86-specific mean fluorescence intensity :::: 2 times than immature DCs were used for further studies.
Exposure ofTHP-1 and DCs cells to chemicals
Aliquots of fresh aqueous mother solutions of the compounds tested were diluted in complete medium. DNCB was the only chemical that was previously diluted in DMSO (l %) before subsequent progressive dilutions with culture medium.
Dose-effect studies
Both cell types were exposed for 48 h at 37°C and 5% CO 2 to different concentrations of the chemicals ranging from 0.02 to 12.5 ug/ml (DNCB); 0.05-1.0 ug/ml, (PPD); 1.0-10 ug/ml (TMS); 0.17-1.6 ug/rnl (NaltCI4), 0.0001-0.005% (SDS) and 0.05% DMSO. Cell death was then determined by flow cytometry as PI incorporation. These experiments allowed the determination of those subtoxic doses (i.e. doses inducing < 50% cell death as assessed by PI-incorporation analysis) of the chemicals, which were used for the subsequent experiment.
Studies with subtoxic concentrations
DCs and TPH-I cells were exposed in the same Table I . Flow cytometric analysis Cells were harvested from the cultures and counted. Aliquots of 10 5 cells (50 ml PBS+ I0% FBS) per tube were obtained. Cells were incubated with 10 III the monoclonal antibody (mAb) conjugated to fluorescein isothiocyanate (F1TC) for 10 min on ice and washed twice. The mAb to human C080-FITC or C086-FITC was combined with propidium iodide (PI) staining to simultaneously measure the percentage of dead cells. To this aim, a PI working solution was added to IO'celles. The PI working solution was prepared by diluting 1 ml PI stock solution (I mg/ ml PI in water) in 20 ml PI buffer (I g glucose in PBS without Ca/Mg). A gate was set on the negative cells in order to exclude the dead cells ( Fig. 1, top panels) . Only viable cells were included for analyses of C080 or C086 expression.
. Modulation of CD80 and CD86 in DC, or TPH-I cells exposed to potent (DNBC, PPD), strong (TMS), moderate (Pt(ll)) sensitising and non-sensitising, irritating (SDS) compounds for 48 h compared to DMSO (vehicle for skin sensitisation). Values are expressed as median and inter-quartile ranges (in parenthesis) ofNrMFI (For details see Materials and Methods, section "Data presentation and statistical analysis ").
Data presentation and statistical analysis
In each experiment, the results of the phenotypic analysis were expressed as mean fluorescence intensity (MFI) in arbitrary units for the given marker. In order to obtain fluorescence values not susceptible to interexperiment variability in the setting of the fluorimeter parameters, the relative MFI (rMFI) was extrapolated for each sample, which corresponded to the ratio between the MFI of C080-or C086-specific MFI and the MFI of another sample of the same cells reacted with an isotype-matched fluoresceinated mAb with irrelevant specificity (Fig. 1, bottom panels) . Finally, in order to prevent the effect of different absolute C080-or C086associated fluorescence values in different experiment, due to inter-individual variability of expression or other technicalities, the normalized rMFI (NrMFI) value was extrapolated. NrMFI represented the ratio of the C080-or C086-specific rMFI of the sample treated with a given chemical versus the C080-or C086-specific rMFI of the untreated cells, respectively. As an example, Fig. 2 shows the results of the parallel evaluation ofNrMFI in OCs and THP-I cells treated with ONCS. Thus, the NrMFI equals the unity in untreated cells in each single experiment, and its variation represents an absolute value of the effect of a given substance on the membrane expression of CD80 or C086by DCs or THP-I cells. In each experiment only the . . concentration yielding the highest difference in NrMFI as compared to venicleOMSO was used for the statistical analysis. . .
Since the relatively small sample size did not allow to establish whether data were normally distributed or not, the Student t-test was not used. Instead Anti-CD86-mc 10F ig. 1 
. Gating strategy for the assessment ofCD86 membrane expression on THP-J cells and calculation ofthe relative mean fluorescence intensity (rMFI). Flow cytometry profiles are shown ofcells reacted with PI and a FITC-conjugated mouse IgGJ, k monoclonal antibody, either endowed with irrelevant specificity (left panels) or binding to human CD86 (right panels). The top panels refer to the dot-plot analysis of a physical parameter (SSC, side scatter, on the x-axis) versus PI-staining, which is a marker of cell death (FL-2, on the y-axis). Gate RJ indicate living cells, which were subsequently subjected to histogram analysis (bottom panels). Lower panel histograms depict specific fluorescence intensity (in arbitrary fluorescence channels, indicated as A. U. on the x-axis) ofevents gated in the respective top panel (number ofevents are on the y-axis). The rMFI is the ratio between the MFI ofCD86-FITC stained sample and the MFI ofthe sample reacted with the irrelevant monoclonal antibody, as indicated.
treated sample of one individual (in the case of Des) or of one test (in the case ofTHP-l) versus the value ofNrMFI of the given chemical treated-sample differed in size. Values ofp < 0.05 were considered as significant. Fig. 3 shows the results of the dose-effect studies concerning the exposure ofOCs and TPH-l cells for 48 h to different concentrations (0.002-12.5 ug/ml) of the potent sensitizing compound ONBC, and of a non-sensitizing, irritating agent (SOS, 0.0001-0.0015%).
RESULTS
[)ose-eJrectstudies
The following conclusions can be drawn: (i) At exposure as low as 2 ug/ml ONCB the cell death was around 30% as determined by PH.
Concentrations of 10 ug/ml and 12.5 ug/ml induced 50% (lC so ) and complete cell mortality, respectively. A concentration of 0.5 ug/ml of ONBC was drawn as subtoxic concentration for the subsequent study of C080 and C086 expression compared to OMSO. In both cell lines the highest C080 and C086 expression was achieved at 0.5 ug/ml ofONCB. (ii) At exposure as low as 0.005% SOS the cell death was of the order 000% while a complete cell mortality was observed at 0.015% exposure. A subtoxic SOS concentration of 0.0075% was drawn for the subsequent study of C080 and C086 expression compared to OMSO. C080 and C086 expression was constant at subtoxic as well as at other SOS tested concentrations. of the other chemicals investigated (PPD, TMS, NaltCl4 figures not shown) the following subtoxic concentrations were drawn for the subsequent study of CD80 and CD86 expression compared to DMSO: 0.5 ug/ml (PPD); 2 ug/ml (TMS) and 0.84 ug/ml (NaltCIJ Table I summarizes the results of the CD80 and CD86 expression in DCs cells exposed for 48 h to selected subtoxic concentrations of potent (DNCB and PPD), strong (TMS), moderate (Na 2PtCI4) sensitizing-and of the non-sensitizing, irritating (SDS) compounds compared to a vehicle for skin sensitization testing (DMSO). Values are expressed as CD80 and CD86-specific NrMFI. The following conclusions can be drawn: (i) incubation with 0.5 ug/ml of DNCB allows a significant increase of the median values of both CD80 and CD86-specific NrMFI as compared to DMSO (p=00.016 and 0.015 respectively).
Modulating expression of CD80 and CD86 in DCs cells
Similar results were observed for the exposure to 0.5 ug/ml of the second potent sensitizing chemical (PPD, p=0.031 for both CD80 and CD86). (ii) exposure to 2 ug/ml ofTMS did not significantly increase CD80 (p=0.063) but increased CD86 (p=0.031) expression. (iii) incubation with 0.84 ug/ml of NaltCl4 led to similar expression patterns to those obtained from the exposure to TMS: no significant increase of CD80 (p=0.063) and up regulation of CD86 (p=0.031). (iv) nor did 0.0075% of SDS significantly change either CD80 or CD86 expression (p=0.813 and I, respectively).
Modulating expression of CD80 and CD86 in THP-l cells
Table I also reports the corresponding data obtained on THP-I cells: (i) exposure of the cells to 0.5 ug/ml of DNCB led to an increase in both CD80 and CD86 (6, 8, (13) (14) . The recent ECVAM Workshop 51 Report reviewed the current status of the use of cultured DCs as a tool for the predicti ve identification of skin sensitisation hazard (15) . The same Report also suggests that stable cell lines should be considered as potential useful tools in this context, warranting further investigations on human myeloid undifferenti ated U-937 and THP-1 cell lines (15) . The present work specifically compares DCs and TPH-I cells as tools for the in vitro prediction of allergenicity. We tested chemical s with different degrees of sensitizing potential over wide concentration ranges , and adopted several precautions to limit the effect of inter-individual and batch-to-batch variability of DCs.
Our results confirm the possibility of using the expression of selected co-stimulatory molecules (CD80 and C086) on DCs and THP-I cells as virtually equivalent endpoints in testing for prediction of skin sensitization of chemicals , and also highlight specific limitation s. Although THP-l cells may have a relatively heterogeneous composition in terms of the differentiation stage of its cellular components, as compared to DCs they have the advantage of being less expensive, not subjected to limitation s in availability and much easier to be cultured. Our data support the notion that, in a tiered in vitro testing strategy to predict skin sensitisation hazard of chemicals, a THP-I pre-screening should eliminat e potent, strong and moderat e sensitising compounds before further predicti ve DCs testing. Additional investigations on a larger number of chemicals with quantitatively known allergenicity are needed to clarify this issue. In particular, two topics should be addressed. The first one concerns the extent of the metabolic activity of DCs and THP-l cells and whether this is sufficient for the routine identification of pro-haptens (15) . The second concern s the effect of speciation on the biological response which is measured in vitro (16) (17) . How different inorganic and metallorganic species of an individual element influences the expression of membrane biomarkers is of fundamental importance for a full estimation of the performance of the cellular models for assessing the skin sensitisation hazard of chemicals. l expression (p=0.031 and 0.016 respectively) (ii) incubation with 0.5 ug/rnl of PPO resulted in an increase of C086 (p=0.031) but not of C080 (p=O.l25) markers (iii) cells exposed to 2 ug/ml ofTMS did not change the C080 expression (p=0.063) whereas C086 biomarker was up regulated (p=0.03 1) (iv) concentration of 0.84 ug/rnl of Na2PtCI4 did not vary the expression of C0 80 membran e marker (p=0.125) but significantly increased C086 expres sion (p=0.03 1) (v) 0.0075% of SOS in culture medium did not affect the modulation of both C080 and C086 (p=1). DCs cells are among the best candidates for designing in vitro alternative approaches to animal test methods aimed at identifying skin sensitisin g
